Top Industry Leaders in the Mitral Valve Stenosis Market
Latest Mitral Valve Stenosis Companies Updates:
Edwards Lifesciences' debut of the TAVR MitraClip system: This transcatheter mitral valve repair device received FDA approval for treating severe symptomatic MVS in patients at high surgical risk, offering a minimally invasive alternative to surgery.
Abbott's MitraClip expansion: The company received FDA approval for the MitraClip system to treat secondary MVS with moderate regurgitation, broadening its application within the MVS market.
Boston Scientific's commitment to TMVR development: This company continues to invest in research and development of transcatheter mitral valve replacement technologies, aiming to bring safe and effective options to the market.
Medtronic's focus on surgical repair solutions: This company maintains its focus on improving MVS surgical repair techniques and tools, offering surgeons various options based on patient needs and complexity.
List of Mitral Valve Stenosis Key companies in the market:
- Medtronic Plc
- Edward Lifesciences
- Boston Scientific Corporation
- Abbott Laboratories
- HighLife Medical
- Neovasc Inc.
- CryoLife, Inc.
- On-X Life Technologies, Inc.
- Micro Interventional Devices, Inc.
- Braun Melsungen AG
- JenaValve Technology